Fasinumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | HNGF |
Identifiers | |
CAS Number | 1190239-42-9 |
ATC code | none |
ChemSpider | none |
Chemical data | |
Formula | C6406H9896N1700O2026S46 |
Molar mass | 144.6 kg/mol |
Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1] Fasinumab for acute sciatic pain[2]
This drug was developed by Regeneron Pharmaceuticals.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
- ↑ http://www.dovepress.com/fasinumab-regn475-an-antinerve-growth-factor-monoclonal-antibody-for-t-peer-reviewed-article-JPR
|
This article is issued from Wikipedia - version of the Wednesday, May 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.